These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12462431)

  • 21. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
    Martinot JB; Carr WD; Cullen S; Heredia Budo JL; Bauer K; MacLeod C; Sanguinetti CM; van Veldhuizen WC;
    Adv Ther; 2001; 18(1):1-11. PubMed ID: 11512528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral telithromycin 800 mg once daily for 5 days versus cefuroxime axetil 500 mg twice daily for 10 days in adults with acute exacerbations of chronic bronchitis.
    Zervos MJ; Heyder AM; Leroy B
    J Int Med Res; 2003; 31(3):157-69. PubMed ID: 12870368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.
    Bucher HC; Tschudi P; Young J; Périat P; Welge-Lüussen A; Züst H; Schindler C;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1793-8. PubMed ID: 12912714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis.
    Luterman M; Tellier G; Lasko B; Leroy B
    Ear Nose Throat J; 2003 Aug; 82(8):576-80, 82-4, 586 passim. PubMed ID: 14503094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short courses of antibiotic in acute otitis media and sinusitis infections.
    Pichicero M
    J Int Med Res; 2000; 28 Suppl 1():25A-36A. PubMed ID: 11092227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group.
    Weis M; Hendrick K; Tillotson G; Gravelle K
    Clin Ther; 1998; 20(5):921-32. PubMed ID: 9829444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
    Lode H; File TM; Mandell L; Ball P; Pypstra R; Thomas M;
    Clin Ther; 2002 Nov; 24(11):1915-36. PubMed ID: 12501883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis.
    Henry DC; Riffer E; Sokol WN; Chaudry NI; Swanson RN
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2770-4. PubMed ID: 12936972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial.
    Matho A; Mulqueen M; Tanino M; Quidort A; Cheung J; Pollard J; Rodriguez J; Swamy S; Tayler B; Garrison G; Ata A; Sorum P
    PLoS One; 2018; 13(5):e0196734. PubMed ID: 29738561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
    Guest N; Langan CE
    Int J Antimicrob Agents; 1998 Apr; 10(1):49-54. PubMed ID: 9624543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of oral fleroxacin with oral amoxicillin/clavulanate for treatment of skin and soft tissue infections.
    Smith JW; Nichols RL
    Am J Med; 1993 Mar; 94(3A):150S-154S. PubMed ID: 8452172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriological efficacy of 5-day therapy with telithromycin in acute maxillary sinusitis.
    Buchanan P; Roos K; Tellier G; Rangaraju M; Leroy B
    Int J Antimicrob Agents; 2005 Mar; 25(3):237-46. PubMed ID: 15737519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.
    Petitpretz P; Chidiac C; Soriano F; Garau J; Stevenson K; Rouffiac E;
    Int J Antimicrob Agents; 2002 Aug; 20(2):119-29. PubMed ID: 12297361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections.
    Bucko AD; Hunt BJ; Kidd SL; Hom R
    Clin Ther; 2002 Jul; 24(7):1134-47. PubMed ID: 12182257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ; Grossman RF; Zadeikis N; Fisher AC; Walker K; Ambruzs ME; Tennenberg AM
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis.
    Jackson J; Fernandes AW; Nelson W
    Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE; Graham JA; Rauch AM; Collins JJ
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.